Michael J Mason
Overview
Explore the profile of Michael J Mason including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
66
Citations
1023
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Urban and Rural Differences in the Efficacy of a Mobile Health Depression Treatment for Young Adults
Mennis J, Coatsworth J, Russell M, Zaharakis N, Brown A, Mason M
Int J Environ Res Public Health
. 2025 Jan;
21(12.
PMID: 39767414
Depression among young adults represents a growing health problem in the U.S., but access to effective treatment remains a challenge. Mobile health (mHealth) approaches promise to deliver accessible and effective...
2.
Mason M, Coatsworth J, Riggs N, Russell M, Mennis J, Zaharakis N, et al.
J Subst Use Addict Treat
. 2024 Dec;
170:209611.
PMID: 39730041
Background: Two scientific and clinical challenges for treating cannabis use disorder (CUD) are developing efficacious treatments with high likelihood of uptake and scalability, and testing the clinical mechanisms by which...
3.
Brindle A, Ballo G, Caley C, Mason M, Bennett V W
Mil Med
. 2024 Oct;
PMID: 39449632
Paederus dermatitis, also known as dermatitis linearis, is an acute cutaneous condition caused by contact with the potent vesicant toxin paederin, produced by endosymbiotic Pseudomonas-like bacteria within Paederus spp. beetles....
4.
Mennis J, Stahler G, Mason M
Addiction
. 2024 Oct;
120(1):171-173.
PMID: 39402865
No abstract available.
5.
Zhang L, Oshri A, Carvalho C, Uddin L, Geier C, Nagata J, et al.
Sleep
. 2024 Oct;
48(1).
PMID: 39390801
Study Objectives: Early exposure to mature content is linked to high-risk behaviors. This study aims to prospectively investigate how sleep and sensation-seeking behaviors influence the consumption of mature video games...
6.
Alexander J, Linkersdorfer J, Toda-Thorne K, Sullivan R, Cummins K, Tomko R, et al.
Sci Rep
. 2024 Aug;
14(1):17982.
PMID: 39097657
Youth screen media activity is a growing concern, though few studies include objective usage data. Through the longitudinal, U.S.-based Adolescent Brain Cognitive Development (ABCD) Study, youth (m = 14; n ...
7.
Zaharakis N, Coatsworth J, Riggs N, Radford A, Rayburn S, Mennis J, et al.
Contemp Clin Trials
. 2024 Jul;
144:107635.
PMID: 39019156
Background: Approximately 16.5% of U.S. young adults have a cannabis use disorder (CUD) and are at risk for negative outcomes. Treatment can reduce cannabis use, but young adults are less...
8.
Mennis J, Mason M, Coatsworth J, Russell M, Zaharakis N
Am J Prev Med
. 2023 Oct;
66(2):333-341.
PMID: 37778528
Introduction: The co-occurrence of depression with cannabis use worsens both mood and substance use disorder outcomes, with young adults particularly at risk of co-occurrence. This research investigates whether the association...
9.
Mason M, Coatsworth J, Zaharakis N, Russell M, Brown A, McKinstry S
JMIR Mhealth Uhealth
. 2023 Jul;
11:e45186.
PMID: 37432723
Background: Current psychiatric epidemiological evidence estimates that 17% of young adults (aged 18-25 years) experienced a major depressive episode in 2020, relative to 8.4% of all adults aged ≥26 years....
10.
Mason M, Coatsworth J, Zaharakis N, Russell M, Wallis D, Brown A, et al.
Behav Ther
. 2023 Mar;
54(2):315-329.
PMID: 36858762
Young adults (ages 18 to 25) in the U.S. suffer from the highest rates of past-year major depressive episode and are the least likely to receive treatment compared to other...